Skip to content

MDMA: all studies

Page 60 of 345: studies 591 to 600 of 3,446, newest first. Back to the MDMA overview

Research

Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Pharmacology, Biochemistry, and Behavior April 2020 Dawn E Muskiewicz, Federico Resendiz-Gutierrez, Omar Issa et al.

Synthetic psychoactive cathinones (SPCs) are drugs with psychostimulant and entactogenic properties like methamphetamine (MA) and 3,4-methylenedioxymethamphetamine (MDMA). Despite clinical reports of human overdose, it remains to be determined if SPCs have greater propensity for adverse effects than MA or MDMA. To determine whether the SPCs cathinone (CAT), methcathinone (MCAT), mephedrone...

Antibody Gene Therapy Mitigates Adverse Immunological Effects of 3,4‐Methylenedioxymethamphetamine (MDMA) in Male BALB/c Mice

The FASEB Journal April 1, 2020 Chris Bolden, Cameron Tilley, Charles E Hay et al.

3,4‐Methylenedioxymethamphetamine (MDMA) is a popular recreational psychostimulant and hallucinogen typically used in “rave” settings. Despite the “positive” feelings sometimes associated with its use, there are toxicities that accompany its use. In the periphery, MDMA causes immunosuppression that can make users more susceptible to infection. Conversely, in the CNS MDMA initiates a...

3,4-Methylenedioxymethamphetamine (MDMA) - Assisted psychotherapy for treatment of posttraumatic stress disorder: Literature review

Romanian Journal of Psychiatry & Psychotherapy March 31, 2020 Tiberiu Constantin Ionescu, Ionut-Stelian Popa, Alin Chiriac et al.

Objectives Post-traumatic stress disorder (PTSD) is a severe psychiatric disorder, with disabling potential and chronic evolution, that occurs at some people due to exposure to a specific traumatic event or threats of death, serious injury or sexual violence. Currently, psychotherapy is accepted as one of the most effective methods of treating PTSD. Incomplete clinical response as well as...

DOI: 10.37897/rjpp.2020.1.3 (opens in new tab) MDMA Addiction Psychotherapist Posttraumatic stress +1

MDMA interactions with pharmaceuticals and drugs of abuse

Expert Opinion on Drug Metabolism & Toxicology March 31, 2020 Esther Papaseit, Clara Pérez‐mañá, Marta Torrens et al. 34 citations

Introduction: MDMA (3,4-methylenedioxymethamphetamine), a synthetic ring-substituted amphetamine, has become one of the most widely used recreational psychostimulant drugs in the world. Among recreational ecstasy/MDMA users, polydrug use is a phenomenon whose common purpose is to experience the synergistic effect of the combined drugs, moderate MDMA effects, prevent potential toxicity, enhance...

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder

Journal of Traumatic Stress February 19, 2020 Ingmar Gorman, Alexander Belser, Lisa Jerome et al. 43 citations Expression of concern

Abstract 3,4‐Methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder (PTSD) has been shown to significantly reduce clinical symptomatology, but posttraumatic growth (PTG), which consists of positive changes in self‐perception, interpersonal relationships, or philosophy of life, has not been studied with this treatment. Participant data ( n = 60) were pooled...

DOI: 10.1002/jts.22479 (opens in new tab) MDMA Placebo Posttraumatic stress Posttraumatic growth +3

Case of Cardiac Arrest Treated with Extra-Corporeal Life Support after MDMA Intoxication

Case Reports in Critical Care January 26, 2020 Pierre Voizeux, Romain Lewandowski, Theresa Daily et al. 7 citations

Objective. To describe the case of a patient who developed a serotonin syndrome due to a 3,4-methylenedioxymethamphetamine ingestion with electrical storm and refractory cardiac arrest. Design. Case report. Study Selection. ICU of a university hospital. Patient. A 22-year-old man transferred to the emergency room with hyperthermia, tremors, and mydriasis presented a cardiac arrest due to...

Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing

Neuropsychopharmacology January 24, 2020 Carla Agurto, Guillermo Cecchi, Raquel Norel et al. 33 citations

Abstract The detection of changes in mental states such as those caused by psychoactive drugs relies on clinical assessments that are inherently subjective. Automated speech analysis may represent a novel method to detect objective markers, which could help improve the characterization of these mental states. In this study, we employed computer-extracted speech features from multiple domains...

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

Drug and Alcohol Dependence January 13, 2020 Michael D. Berquist, Sebastian Leth-Petersen, Jesper L. Kristensen et al.

BACKGROUND Recent clinical studies support the use of 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct treatment for posttraumatic stress disorder (PTSD). Despite these promising findings, MDMA administration in controlled settings can increase blood pressure, heart rate, and body temperature. Previous studies indicate thatO-demethylated metabolites of MDMA contribute to its adverse...

Multivisceral Failure in a Context of Serotonin Syndrome Induced by MDMA: The Investigation of a Unique and Nationwide Network.

Journal of Addiction Medicine 2020 Elise Humeau, Hugo Peyre, Gregory Pfau et al.

: The occasional ingestion of 3,4-methylenedioxy-N-methylamphetamine (MDMA) presents serious risks of side effects including death through multivisceral failure in a context of serotonin syndrome. The significant increasing evolution of illicit MDMA street dosages over the past 2 decades and the difficulty for physicians to know what quantity the patients may have consumed, make MDMA a drug...

Diffusion of Ecstasy in the Electronic Dance Music Scene.

Substance Use & Misuse 2020 Joseph J Palamar

Ecstasy (MDMA, Molly) is among the most prevalent drugs used by people who attend electronic dance music (EDM) events; however, little recent research has examined diffusion of ecstasy in this high-risk population. Methods: 1,020 EDM event-attending adults (aged 18-40) were surveyed in NYC in 2018 using time-spacing sampling. Participants were asked about past-year ecstasy use, and those...